biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by lovincoalon Jun 28, 2016 10:27pm

85 Views

Post# 25007089

why are we at $1.17 if things are so great ?

it's hard to imagine things being great if the stock is only at $1.17. You would think that those "in the know" would be lapping up all these cheap shares.
I'd also be curious to know why there was a single order ASK for 178k shares @ $1.42 for the past 2 weeks. It's a big order relative to the daily avg trading volume.
Also, why doesn't the CEO get some analyst coverage - us small fry can only move the stock so far without bigger funds/institutions getting onboard. Is there any brokerage coverage for BTI now ?

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment